TET2 and chronic myelomonocytic leukemia: Importantly, one third of Tet2 -/- and 8% of Tet2 +/- mice died within 1 year of age because of the development of myeloid malignancies reminiscent of CMML indicating that Tet2 loss may represent a predisposition for the development of this malignancy.